Influential hydroxychloroquine data came from a small U.S. company that is allegedly 'almost certainly a scam'
The legitimacy of the company Surgisphere, which provided global policy-altering coronavirus data, has been called into question, The Guardian reports after conducting an investigation into the little-known U.S. healthcare analytics firm.
Several governments in Latin America changed their COVID-19 treatment policies based on data Surgisphere claims it obtained from more than a thousand hospitals across the world, and the World Health Organization halted its trials of the controversial malaria drug hydroxychloroquine, which has been touted by President Trump, for the same reason. There are still many concerns about hydroxychloroquine's effectiveness and safety among the scientific and medical communities, but there's simultaneously growing skepticism about studies that involved Surgisphere's data.
Two of the world's leading medical journals, The Lancet and the New England Journal of Medicine, are now expressing concern about the reliability of the data used in hydroxychloroquine studies they published, which found the drug was associated with a higher mortality rate among COVID-19 patients. And The Guardian reports seven hospitals in Australia that were included in Surgisphere's database said they had never even heard of the company, let alone cooperated in its data collection.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Guardian's investigation also reveals several of Surgisphere's employees have little or no scientific background (one "science editor" appears to be a science fiction author), the company has a limited online presence and lacks a way for hospitals to get in touch and provide data, and its chief executive, Sapan Desai, has been named in three medical malpractice suits. Desai denies the company is illegitimate, but Peter Ellis, the chief data scientist of the international management consulting firm Nous Group, told The Guardian that Surgisphere is "almost certainly a scam." Read more at The Guardian.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Iowa's Caitlin Clark breaks NCAA scoring record
speed read College basketball star Caitlin Clark set the new record in Iowa's defeat of Ohio State
By Peter Weber, The Week US Published
-
Eight-year-old Brit Bodhana Sivanandan makes chess history
Speed Read Sivanandan has been described as a 'phenomenon' by chess masters
By Sorcha Bradley, The Week UK Published
-
Watch Simone Biles win her record 8th US gymnastics championship
Speed Read
By Peter Weber Published
-
Spain beats England 1-0 to win its first Women's World Cup
Speed Read
By Justin Klawans Published
-
US knocked out of Women's World Cup in stunning exit
Speed Read
By Justin Klawans Published
-
Katie Ledecky surpasses Michael Phelps for most world championship titles
Speed Read
By Justin Klawans Published
-
Marketa Vondrousova becomes first unseeded woman to win Wimbledon
Speed Read
By Justin Klawans Published
-
Former Mets player receives annual $1.1M payout despite retiring in 2001
Speed Read
By Justin Klawans Published